Mesoblast Limited vs Micron Technology, Inc. — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Micron Technology, Inc. trades at $892.18 (market cap $980.90B). The key difference: Micron Technology, Inc. is far larger — about 443.8× Mesoblast Limited's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | MU | |
|---|---|---|
Market Cap | $2.21B | $980.90B |
Sector | Technology | Technology |
52-Week High | $20.96 | $1.21K |
52-Week Low | $12.88 | $115.79 |
Enterprise Value | $2.21B | $961.25B |
Dividend Yield | — | 0.06% |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →